**Core Concept**
The concept of "extension for prevention" is related to the mechanism of action of certain drugs, specifically anticoagulants, that prevent thrombosis by prolonging the coagulation cascade. This involves the inhibition of specific enzymes involved in the coagulation pathway.

**Why the Correct Answer is Right**
Extension for prevention is a characteristic of anticoagulants that prevent thrombosis by prolonging the coagulation cascade. This is achieved through the inhibition of Factor Xa, which is a key enzyme in the coagulation pathway. The extension of the coagulation pathway prevents the conversion of prothrombin to thrombin, thereby preventing the formation of fibrin clots. This mechanism is particularly relevant to drugs such as apixaban, rivaroxaban, and edoxaban, which are direct Factor Xa inhibitors.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because it does not accurately describe the mechanism of action of anticoagulants that prevent thrombosis.
**Option B:** This option is incorrect because it refers to the concept of "extension for treatment", which is a different concept from "extension for prevention".
**Option C:** This option is incorrect because it is not directly related to the concept of "extension for prevention" in the context of anticoagulants.

**Clinical Pearl / High-Yield Fact**
It is essential to understand the differences between anticoagulants that prevent thrombosis and those that treat established thrombosis, as this can impact treatment decisions and patient outcomes.

**Correct Answer: D. Factor Xa inhibitors. Anticoagulants that prevent thrombosis by prolonging the coagulation cascade through the inhibition of Factor Xa.**